No cure exists for frontotemporal dementia, which strikes between the ages of 40 and 64 and accounts for at least one in four cases of early-onset dementia. Caused by the death of cells in the front and sides of the brain, the disease can lead to dramatic changes in a patient’s personality and behavior, including [...]
Posts Tagged ‘Consortium for Frontotemporal Dementia’
Potential Target for Treating Common Form of Early-Onset Dementia Identified
September 29th, 2011 
admin 
Posted in Articles, Resources 
Tags: activity, alleviate, Alzheimer's Foundation, behavior, communicate, Consortium for Frontotemporal Dementia, Cure, David Geffen, Dementia, Disease, disorder, Dr. Daniel Geschwind, Drug, early-onset, frontotemporal, genetic, John Douglas French Alzheimer's Foundation, mental health, National Institute for Neurological Disease and Stroke, National Institute of Aging, National Institute of Mental Health, neurology, new drug, personality, Reference, Research, Semel Institute, Semel Institute for Neuroscience and Human Behavior, stem cells, symptoms, The journal Neuron, Treatment, UC San Francisco, UCLA, University of California Los Angeles 
No Comments »
